Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Change in Cash (2020 - 2025)

Celularity (CELU) has disclosed Change in Cash for 6 consecutive years, with -$681000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Cash fell 205.38% to -$681000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$76000.0, a 98.41% increase, with the full-year FY2024 number at $814000.0, up 104.37% from a year prior.
  • Change in Cash was -$681000.0 for Q3 2025 at Celularity, down from $632000.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $64.5 million in Q3 2021 to a low of -$35.4 million in Q4 2021.
  • A 5-year average of -$3.1 million and a median of -$1.4 million in 2024 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: crashed 7520.18% in 2021, then skyrocketed 145.34% in 2025.
  • Celularity's Change in Cash stood at -$35.4 million in 2021, then increased by 18.9% to -$28.7 million in 2022, then soared by 82.79% to -$4.9 million in 2023, then skyrocketed by 113.09% to $646000.0 in 2024, then tumbled by 205.42% to -$681000.0 in 2025.
  • Per Business Quant, the three most recent readings for CELU's Change in Cash are -$681000.0 (Q3 2025), $632000.0 (Q2 2025), and -$673000.0 (Q1 2025).